- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting CXCL12/CXCR4 Axis in Tumor Immunotherapy
Authors
Keywords
-
Journal
CURRENT MEDICINAL CHEMISTRY
Volume 26, Issue 17, Pages 3026-3041
Publisher
Bentham Science Publishers Ltd.
Online
2017-09-14
DOI
10.2174/0929867324666170830111531
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- miR-204-5p regulates cell proliferation and metastasis through inhibiting CXCR4 expression in OSCC
- (2016) Xinjuan Wang et al. BIOMEDICINE & PHARMACOTHERAPY
- An Evaluation of the Impact of PD-1 Pathway Blockade on Reproductive Safety of Therapeutic PD-1 Inhibitors
- (2016) Frederique M. Poulet et al. BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY
- Beyond melanoma: inhibiting the PD-1/PD-L1 pathway in solid tumors
- (2016) Ryan Gentzler et al. Immunotherapy
- The Role of Chemokines in Promoting Colorectal Cancer Invasion/Metastasis
- (2016) Yoshiro Itatani et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- D-α-Tocopheryl polyethylene glycol succinate/Solutol HS 15 mixed micelles for the delivery of baohuoside I against non-small-cell lung cancer: optimization and in vitro, in vivo evaluation
- (2016) Hong-mei Yan et al. International Journal of Nanomedicine
- Atypical chemokine receptors in cancer: friends or foes?
- (2016) Matteo Massara et al. JOURNAL OF LEUKOCYTE BIOLOGY
- PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
- (2016) Weiping Zou et al. Science Translational Medicine
- Expression of C-X-C chemokine receptor type 7 in otorhinolaryngologic neoplasms
- (2016) T Tang et al. SINGAPORE MEDICAL JOURNAL
- Oncogenic roles and drug target of CXCR4/CXCL12 axis in lung cancer and cancer stem cell
- (2016) Zhidong Wang et al. TUMOR BIOLOGY
- Co-expression of Lgr5 and CXCR4 characterizes cancer stem-like cells of colorectal cancer
- (2016) Weidong Wu et al. Oncotarget
- MicroRNA-126 inhibits colon cancer cell proliferation and invasion by targeting the chemokine (C-X-C motif) receptor 4 and Ras homolog gene family, member A, signaling pathway
- (2016) Wei Yuan et al. Oncotarget
- CXCL12 promoter methylation and PD-L1 expression as prognostic biomarkers in prostate cancer patients
- (2016) Diane Goltz et al. Oncotarget
- Cancer Stem Cell Quiescence and Plasticity as Major Challenges in Cancer Therapy
- (2016) Wanyin Chen et al. Stem Cells International
- CAR T Cell Therapy: A Game Changer in Cancer Treatment
- (2016) Hilde Almåsbak et al. Journal of Immunology Research
- Anti-Cancer Stem-like Cell Compounds in Clinical Development – An Overview and Critical Appraisal
- (2016) Fabrizio Marcucci et al. Frontiers in Oncology
- miR-101 represses lung cancer by inhibiting interaction of fibroblasts and cancer cells by down-regulating CXCL12
- (2015) Jian Zhang et al. BIOMEDICINE & PHARMACOTHERAPY
- HuR-targeted nanotherapy in combination with AMD3100 suppresses CXCR4 expression, cell growth, migration and invasion in lung cancer
- (2015) R Muralidharan et al. CANCER GENE THERAPY
- Diverse Targets of -Catenin during the Epithelial-Mesenchymal Transition Define Cancer Stem Cells and Predict Disease Relapse
- (2015) Y.-W. Chang et al. CANCER RESEARCH
- Microenvironment-Modulated Metastatic CD133+/CXCR4+/EpCAM- Lung Cancer-Initiating Cells Sustain Tumor Dissemination and Correlate with Poor Prognosis
- (2015) G. Bertolini et al. CANCER RESEARCH
- Targeting Notch Signaling with a Notch2/Notch3 Antagonist (Tarextumab) Inhibits Tumor Growth and Decreases Tumor-Initiating Cell Frequency
- (2015) W.-C. Yen et al. CLINICAL CANCER RESEARCH
- CXCR4 inhibition in tumor microenvironment facilitates anti-programmed death receptor-1 immunotherapy in sorafenib-treated hepatocellular carcinoma in mice
- (2015) Yunching Chen et al. HEPATOLOGY
- Studying the binding interactions of allosteric agonists and antagonists of the CXCR4 receptor
- (2015) Jesús M. Planesas et al. JOURNAL OF MOLECULAR GRAPHICS & MODELLING
- Combination Treatment with All-Trans Retinoic Acid Prevents Cisplatin-Induced Enrichment of CD133+ Tumor-Initiating Cells and Reveals Heterogeneity of Cancer Stem Cell Compartment in Lung Cancer
- (2015) Massimo Moro et al. Journal of Thoracic Oncology
- Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
- (2015) Edward B. Garon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
- (2015) Julie Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- CXCL12/CXCR4: a symbiotic bridge linking cancer cells and their stromal neighbors in oncogenic communication networks
- (2015) F Guo et al. ONCOGENE
- GnRH participates in the self-renewal of A549-derived lung cancer stem-like cells through upregulation of the JNK signaling pathway
- (2015) CHI LU et al. ONCOLOGY REPORTS
- Side population cells separated from A549 lung cancer cell line possess cancer stem cell-like properties and inhibition of autophagy potentiates the cytotoxic effect of cisplatin
- (2015) YANG YANG et al. ONCOLOGY REPORTS
- Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
- (2015) N. A. Rizvi et al. SCIENCE
- Clinical Activity, Toxicity, Biomarkers, and Future Development of CTLA-4 Checkpoint Antagonists
- (2015) Margaret K. Callahan et al. SEMINARS IN ONCOLOGY
- CXCL12 and ADAM23 hypermethylation are associated with advanced breast cancers
- (2015) Ivana Fridrichova et al. Translational Research
- Perspective: Cooperation of Nanog, NF-κΒ, and CXCR4 in a regulatory network for directed migration of cancer stem cells
- (2015) Masoumeh Es-haghi et al. TUMOR BIOLOGY
- The Akt1/IL-6/STAT3 pathway regulates growth of lung tumor initiating cells
- (2015) Donatella Malanga et al. Oncotarget
- CXCR4 over-expression and survival in cancer: A system review and meta-analysis
- (2015) Hongli Zhao et al. Oncotarget
- Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target
- (2015) Yongmin Yan et al. Stem Cells Translational Medicine
- Special Conference on Tumor Immunology and Immunotherapy: A New Chapter
- (2015) K. T. Byrne et al. Cancer Immunology Research
- AMD3100/CXCR4 Inhibitor
- (2015) Erik De Clercq Frontiers in Immunology
- Chemokine Receptor-Specific Antibodies in Cancer Immunotherapy: Achievements and Challenges
- (2015) Maria Vela et al. Frontiers in Immunology
- Diversity and Inter-Connections in the CXCR4 Chemokine Receptor/Ligand Family: Molecular Perspectives
- (2015) Lukas Pawig et al. Frontiers in Immunology
- Resveratrol suppresses vascular endothelial growth factor secretion via inhibition of CXC-chemokine receptor 4 expression in ARPE-19 cells
- (2015) HYEMIN SEONG et al. Molecular Medicine Reports
- IL-24 Inhibits Lung Cancer Cell Migration and Invasion by Disrupting The SDF-1/CXCR4 Signaling Axis
- (2015) Janani Panneerselvam et al. PLoS One
- Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers
- (2015) Luisa Carbognin et al. PLoS One
- 4EGI-1 targets breast cancer stem cells by selective inhibition of translation that persists in CSC maintenance, proliferation and metastasis
- (2015) Tingfang Yi et al. Oncotarget
- CXCR4 Inhibition with AMD3100 Sensitizes Prostate Cancer to Docetaxel Chemotherapy
- (2015) Urszula M. Domanska et al. NEOPLASIA
- Reprogramming Using microRNA-302 Improves Drug Sensitivity in Hepatocellular Carcinoma Cells
- (2014) Chikato Koga et al. ANNALS OF SURGICAL ONCOLOGY
- Baohuoside I Suppresses Invasion of Cervical and Breast Cancer Cells through the Downregulation of CXCR4 Chemokine Receptor Expression
- (2014) Buyun Kim et al. BIOCHEMISTRY
- Inhibition of breast cancer metastasis with microRNA-302a by downregulation of CXCR4 expression
- (2014) Zhongxing Liang et al. BREAST CANCER RESEARCH AND TREATMENT
- Antitumour activity of the recombination polypeptide GST-NT21MP is mediated by inhibition of CXCR4 pathway in breast cancer
- (2014) Q Yang et al. BRITISH JOURNAL OF CANCER
- The PRKCI and SOX2 Oncogenes Are Coamplified and Cooperate to Activate Hedgehog Signaling in Lung Squamous Cell Carcinoma
- (2014) Verline Justilien et al. CANCER CELL
- JNK Signaling Mediates EPHA2-Dependent Tumor Cell Proliferation, Motility, and Cancer Stem Cell-like Properties in Non-Small Cell Lung Cancer
- (2014) W. Song et al. CANCER RESEARCH
- Lung Cancer Stem Cells and Implications for Future Therapeutics
- (2014) Jing Wang et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- Close correlation between CXCR4 and VEGF expression and frequent CXCR7 expression in rhabdomyosarcoma
- (2014) Kina Miyoshi et al. HUMAN PATHOLOGY
- Microfluidic source-sink model reveals effects of biophysically distinct CXCL12 isoforms in breast cancer chemotaxis
- (2014) S. P. Cavnar et al. Integrative Biology
- MiR-451 Suppresses Cell Proliferation and Metastasis in A549 Lung Cancer Cells
- (2014) Pin Yin et al. MOLECULAR BIOTECHNOLOGY
- Hypoxia differentially regulated CXCR4 and CXCR7 signaling in colon cancer
- (2014) Benoît Romain et al. Molecular Cancer
- Inhibition of Angiogenesis, Fibrosis and Thrombosis by Tetramethylpyrazine: Mechanisms Contributing to the SDF-1/CXCR4 Axis
- (2014) Xiaoxiao Cai et al. PLoS One
- High-level C-X-C chemokine receptor type 4 expression correlates with brain-specific metastasis following complete resection of non-small cell lung cancer
- (2014) LUNQING WANG et al. Oncology Letters
- Targeting CXCR4 with CTCE-9908 inhibits prostate tumor metastasis
- (2014) Donald Wong et al. BMC Urology
- The Carcinoma-Associated Fibroblast Expressing Fibroblast Activation Protein and Escape from Immune Surveillance
- (2014) D. T. Fearon Cancer Immunology Research
- Inhibition of CXCR4–CXCL12 chemotaxis in melanoma by AMD11070
- (2013) G O'Boyle et al. BRITISH JOURNAL OF CANCER
- Benzenesulfonamides: A Unique Class of Chemokine Receptor Type 4 Inhibitors
- (2013) Suazette Reid Mooring et al. ChemMedChem
- Notch Pathway Activity Identifies Cells with Cancer Stem Cell-like Properties and Correlates with Worse Survival in Lung Adenocarcinoma
- (2013) K. A. Hassan et al. CLINICAL CANCER RESEARCH
- CD44 integrates signaling in normal stem cell, cancer stem cell and (pre)metastatic niches
- (2013) Karin Williams et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- CXCR4, but not CXCR7, Discriminates Metastatic Behavior in Non–Small Cell Lung Cancer Cells
- (2013) Young H. Choi et al. MOLECULAR CANCER RESEARCH
- MicroRNA-9 inhibits the proliferation of oral squamous cell carcinoma cells by suppressing expression of CXCR4 via the Wnt/β-catenin signaling pathway
- (2013) T Yu et al. ONCOGENE
- Concomitant overexpression of EGFR and CXCR4 is associated with worse prognosis in a new molecular subtype of non-small cell lung cancer
- (2013) ALYA A. AL ZOBAIR et al. ONCOLOGY REPORTS
- The CXCR4 Antagonist AMD3465 Regulates Oncogenic Signaling and Invasiveness In Vitro and Prevents Breast Cancer Growth and Metastasis In Vivo
- (2013) Xiaoyang Ling et al. PLoS One
- Differential Effects of Drugs Targeting Cancer Stem Cell (CSC) and Non-CSC Populations on Lung Primary Tumors and Metastasis
- (2013) Leyre Larzabal et al. PLoS One
- Targeting CXCL12/CXCR4 signaling with oncolytic virotherapy disrupts tumor vasculature and inhibits breast cancer metastases
- (2013) M. Gil et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer
- (2013) C. Feig et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cancer stem cells in lung cancer: Evidence and controversies
- (2013) Muhammad Alamgeer et al. RESPIROLOGY
- CXCR4/CXCL12 Axis in Non Small Cell Lung Cancer (NSCLC) Pathologic Roles and Therapeutic Potential
- (2013) Ori Wald et al. Theranostics
- CXCR4 regulates migration of lung alveolar epithelial cells through activation of Rac1 and matrix metalloproteinase-2
- (2012) Manik C. Ghosh et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Lung Cancer Stem Cells as a Target for Therapy
- (2012) Elieser Gorelik et al. Anti-Cancer Agents in Medicinal Chemistry
- Molecular modeling study of cyclic pentapeptide CXCR4 antagonists: New insight into CXCR4–FC131 interactions
- (2012) Yasushi Yoshikawa et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia
- (2012) G. L. Uy et al. BLOOD
- Wnt5a promotes ewing sarcoma cell migration through upregulating CXCR4 expression
- (2012) Zhe Jin et al. BMC CANCER
- ALDH-positive lung cancer stem cells confer resistance to epidermal growth factor receptor tyrosine kinase inhibitors
- (2012) Cheng-Po Huang et al. CANCER LETTERS
- Lung cancer stem cells: Progress and prospects
- (2012) Amber Lundin et al. CANCER LETTERS
- Subpopulation of small-cell lung cancer cells expressing CD133 and CD87 show resistance to chemotherapy
- (2012) Toshio Kubo et al. CANCER SCIENCE
- BMS-936564/MDX-1338: A Fully Human Anti-CXCR4 Antibody Induces Apoptosis In Vitro and Shows Antitumor Activity In Vivo in Hematologic Malignancies
- (2012) M. R. Kuhne et al. CLINICAL CANCER RESEARCH
- Chemokine receptor trio: CXCR3, CXCR4 and CXCR7 crosstalk via CXCL11 and CXCL12
- (2012) Anup Kumar Singh et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Wnt Signaling Regulates Intermediate Precursor Production in the Postnatal Dentate Gyrus by Regulating Cxcr4 Expression
- (2012) Youngshik Choe et al. DEVELOPMENTAL NEUROSCIENCE
- Development of novel CXCR4-based therapeutics
- (2012) Amnon Peled et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Suppression of metastases of small cell lung cancer cells in mice by a peptidic CXCR4 inhibitor TF14016
- (2012) Yasushi Otani et al. FEBS LETTERS
- CD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challenges
- (2012) Philipp Grosse-Gehling et al. JOURNAL OF PATHOLOGY
- Effective inhibition of metastases and primary tumor growth with CTCE-9908 in esophageal cancer
- (2012) Astrid Drenckhan et al. JOURNAL OF SURGICAL RESEARCH
- In vitro and in vivo therapeutic efficacy of CXCR4 antagonist BKT140 against human non–small cell lung cancer
- (2012) Duha Fahham et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
- The Cancer Stem-Cell Hypothesis: Its Emerging Role in Lung Cancer Biology and Its Relevance for Future Therapy
- (2012) John D. O’Flaherty et al. Journal of Thoracic Oncology
- EGFR/Src/Akt signaling modulates Sox2 expression and self-renewal of stem-like side-population cells in non-small cell lung cancer
- (2012) Sandeep Singh et al. Molecular Cancer
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Upregulation of CXCR4 is functionally crucial for maintenance of stemness in drug-resistant non-small cell lung cancer cells
- (2012) M-J Jung et al. ONCOGENE
- Stem Cell Factor Receptor/c-Kit: From Basic Science to Clinical Implications
- (2012) Johan Lennartsson et al. PHYSIOLOGICAL REVIEWS
- Inhibition of CK2α Down-Regulates Hedgehog/Gli Signaling Leading to a Reduction of a Stem-Like Side Population in Human Lung Cancer Cells
- (2012) Shulin Zhang et al. PLoS One
- Development of a Unique Small Molecule Modulator of CXCR4
- (2012) Zhongxing Liang et al. PLoS One
- Involvement of CXCR4 Chemokine Receptor in Metastastic HER2-Positive Esophageal Cancer
- (2012) Stephanie J. Gros et al. PLoS One
- CXCR4 Inhibitors: Tumor Vasculature and Therapeutic Challenges
- (2012) Filomena de Nigris et al. Recent Patents on Anti-Cancer Drug Discovery
- CXCR7 in tumorigenesis and progression
- (2012) Kai-Lin Hou et al. Chinese Journal of Cancer
- Tumor Metastasis: Molecular Insights and Evolving Paradigms
- (2011) Scott Valastyan et al. CELL
- The miR 302-367 cluster drastically affects self-renewal and infiltration properties of glioma-initiating cells through CXCR4 repression and consequent disruption of the SHH-GLI-NANOG network
- (2011) M Fareh et al. CELL DEATH AND DIFFERENTIATION
- CXCL12-CXCR4 Axis in Angiogenesis, Metastasis and Stem Cell Mobilization
- (2011) S. Liekens et al. CURRENT PHARMACEUTICAL DESIGN
- Down-Regulation of CXCL12 by DNA Hypermethylation and Its Involvement in Gastric Cancer Metastatic Progression
- (2011) Yu Zhi et al. DIGESTIVE DISEASES AND SCIENCES
- Chemokines in tumor development and progression
- (2011) Naofumi Mukaida et al. EXPERIMENTAL CELL RESEARCH
- Acetyl-11-keto-β-boswellic acid suppresses invasion of pancreatic cancer cells through the downregulation of CXCR4 chemokine receptor expression
- (2011) Byoungduck Park et al. INTERNATIONAL JOURNAL OF CANCER
- Ginsenoside Rg3 inhibits CXCR4 expression and related migrations in a breast cancer cell line
- (2011) Xiao-ping Chen et al. International Journal of Clinical Oncology
- CXCR7/CXCR4 Heterodimer Constitutively Recruits β-Arrestin to Enhance Cell Migration
- (2011) Fabien M. Décaillot et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The chemokine system and cancer
- (2011) Frances R Balkwill JOURNAL OF PATHOLOGY
- Interaction between neoplastic cells and cancer-associated fibroblasts through the CXCL12/CXCR4 axis: Role in non–small cell lung cancer tumor proliferation
- (2011) Ori Wald et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
- CXCR4 positive cells from Lewis lung carcinoma cell line have cancer metastatic stem cell characteristics
- (2011) Wei-Qi Nian et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
- (2011) David L. Porter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Thymoquinone Inhibits the CXCL12-Induced Chemotaxis of Multiple Myeloma Cells and Increases Their Susceptibility to Fas-Mediated Apoptosis
- (2011) Gamal Badr et al. PLoS One
- Identification of Hepatic Niche Harboring Human Acute Lymphoblastic Leukemic Cells via the SDF-1/CXCR4 Axis
- (2011) Itaru Kato et al. PLoS One
- Boswellic Acid Suppresses Growth and Metastasis of Human Pancreatic Tumors in an Orthotopic Nude Mouse Model through Modulation of Multiple Targets
- (2011) Byoungduck Park et al. PLoS One
- Significance of CXCR4, phosphorylated STAT3 and VEGF-A expression in resected non-small cell lung cancer
- (2011) MENG WANG et al. Experimental and Therapeutic Medicine
- Butein downregulates chemokine receptor CXCR4 expression and function through suppression of NF-κB activation in breast and pancreatic tumor cells
- (2010) Angeline Wei Ling Chua et al. BIOCHEMICAL PHARMACOLOGY
- Molecular characterisation of side population cells with cancer stem cell-like characteristics in small-cell lung cancer
- (2010) C D Salcido et al. BRITISH JOURNAL OF CANCER
- CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression
- (2010) Xueqing Sun et al. CANCER AND METASTASIS REVIEWS
- The role of chemokine receptor CXCR4 in lung cancer
- (2010) Tara Gangadhar et al. CANCER BIOLOGY & THERAPY
- Aldehyde Dehydrogenase Activity Selects for Lung Adenocarcinoma Stem Cells Dependent on Notch Signaling
- (2010) J. P. Sullivan et al. CANCER RESEARCH
- HDAC3 selectively represses CREB3-mediated transcription and migration of metastatic breast cancer cells
- (2010) Han-Cheon Kim et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Evaluation of a CXCR4 antagonist in a xenograft mouse model of inflammatory breast cancer
- (2010) Balraj Singh et al. CLINICAL & EXPERIMENTAL METASTASIS
- Hallmarks of cancer: Interactions with the tumor stroma
- (2010) Kristian Pietras et al. EXPERIMENTAL CELL RESEARCH
- Chemokines as mediators of tumor angiogenesis and neovascularization
- (2010) Ellen C. Keeley et al. EXPERIMENTAL CELL RESEARCH
- CXCR4 antagonist 4F-benzoyl-TN14003 inhibits leukemia and multiple myeloma tumor growth
- (2010) Katia Beider et al. EXPERIMENTAL HEMATOLOGY
- CXCR4 peptide antagonist inhibits primary breast tumor growth, metastasis and enhances the efficacy of anti-VEGF treatment or docetaxel in a transgenic mouse model
- (2010) Saima Hassan et al. INTERNATIONAL JOURNAL OF CANCER
- Enhanced cytotoxicity of IL-24 gene-modified dendritic cells co-cultured with cytokine-induced killer cells to hepatocellular carcinoma cells
- (2010) Xin Yu et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Dipyrimidine Amines: A Novel Class of Chemokine Receptor Type 4 Antagonists with High Specificity
- (2010) Aizhi Zhu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Celastrol suppresses invasion of colon and pancreatic cancer cells through the downregulation of expression of CXCR4 chemokine receptor
- (2010) Vivek R. Yadav et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- HGF upregulates CXCR4 expression in gliomas via NF-κB: implications for glioma cell migration
- (2010) Mine Esencay et al. JOURNAL OF NEURO-ONCOLOGY
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Novel CXCR4 Antagonist KRH-3955 Is an Orally Bioavailable and Extremely Potent Inhibitor of Human Immunodeficiency Virus Type 1 Infection: Comparative Studies with AMD3100
- (2009) T. Murakami et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Blockade of X4-Tropic HIV-1 Cellular Entry by GSK812397, a Potent Noncompetitive CXCR4 Receptor Antagonist
- (2009) S. Jenkinson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The AMD3100 story: The path to the discovery of a stem cell mobilizer (Mozobil)
- (2009) Erik De Clercq BIOCHEMICAL PHARMACOLOGY
- Using naturally occurring tumours in dogs and cats to study telomerase and cancer stem cell biology
- (2009) Lisa Y. Pang et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Chemokines in tumor-associated angiogenesis
- (2009) Peter Arne Gerber et al. BIOLOGICAL CHEMISTRY
- Vesnarinone downregulates CXCR4 expression via upregulation of Krüppel-like factor 2 in oral cancer cells
- (2009) Daisuke Uchida et al. Molecular Cancer
- Plerixafor
- (2009) John F. DiPersio et al. NATURE REVIEWS DRUG DISCOVERY
- Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment
- (2009) G. Bertolini et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inhibitory effect of HGF on invasiveness of aggressive MDA-MB231 breast carcinoma cells and role of HDACs
- (2008) E Ridolfi et al. BRITISH JOURNAL OF CANCER
- Role of the CXCR4/CXCL12 signaling axis in breast cancer metastasis to the brain
- (2008) Cimona V. Hinton et al. CLINICAL & EXPERIMENTAL METASTASIS
- Pharmacokinetic Effect of AMD070, an Oral CXCR4 Antagonist, on CYP3A4 and CYP2D6 Substrates Midazolam and Dextromethorphan in Healthy Volunteers
- (2008) Myaing M Nyunt et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- A CXCR4 Antagonist CTCE-9908 Inhibits Primary Tumor Growth and Metastasis of Breast Cancer
- (2008) Eugene H. Huang et al. JOURNAL OF SURGICAL RESEARCH
- CXCL12 and CXCR4 in adenocarcinoma of the lung: Association with metastasis and survival
- (2008) Patrick L. Wagner et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
- CXCL12/CXCR4 Transactivates HER2 in Lipid Rafts of Prostate Cancer Cells and Promotes Growth of Metastatic Deposits in Bone
- (2008) S. R. Chinni et al. MOLECULAR CANCER RESEARCH
- A three-step pathway comprising PLZF/miR-146a/CXCR4 controls megakaryopoiesis
- (2008) Catherine Labbaye et al. NATURE CELL BIOLOGY
- Co-evolution of tumor cells and their microenvironment
- (2008) Kornelia Polyak et al. TRENDS IN GENETICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now